Skip to content
Recall Observatory FDA recall evidence

Drug product

Naftifine Hydrochloride Gel, USP 1%, packaged in cartons with: a) Net Wt. 90g tube (NDC 0115-1510-48), b) Net Wt. 40g tube (NDC 0115-1510-63), c) Net Wt. 60g tube (NDC 0115-1510-58), Rx only, Manufactured by: Tolmar, Inc., Fort Collins, CO, 80526, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807

D-1300-2022

July 11, 2022

Class II

Product summary

Firm
Tolmar, Inc.
Event
Event 90580
Status
Terminated
Classification
Class II
Quantity
1271 tubes
Official record key
drug-enforcement:D-1300-2022

Official wording

Reason: Failed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention Time

Code information: Lot #: a) 12070A, Exp 5/2023; 11801A, Exp 9/2022; b) 12386A, Exp 8/2023; 11800A, Exp 9/2022; c) 11940A, Exp 12/2022

Distribution pattern: distributed to 1 consignee in KY.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-Specification